FDA Approves Biosimilar

Article

The FDA today announced the approval of the biosimilar product infliximab-abda.

Officials with the FDA have announced the approval of infliximab-abda (Renflexis, Samsung Bioepis), which is a biosimilar to infliximab (Remicade, Janssen).

The announcement was made by the FDA via Twitter earlier this afternoon.

Infliximab is used in the treatment of Crohn’s disease and ulcerative colitis in both children and adults who have not responded to other therapies, as well as various forms of arthritis, including rheumatoid and psoriatic, as well as ankylosing spondylitis, and plaque psoriasis.

The similarity between Renflexis and the reference product has been demonstrated for indications, dosing, and administration. While the inactive ingredients vary between the 2 drugs, there are no clinically meaningful differences in safety and efficacy. Common adverse events include upper respiratory infections, sinusitis, and pharyngitis, infusion-related reactions, headache, and abdominal pain, according to the FDA.

According to this recently-published column in Pharmacy Times, this approval follows in a line of biosimilar approvals in recent years.

"In March of 2015, Zarxio (filgrastim-sndz), a biosimilar for of Neupogen, was the first biosimilar approved. Zarxio was followed by Inflectra (infliximab-dyyb) in April 2016, Erelzi (etanercept-szzs) in August 2016, and Amjevita (adalimumab-atto) in September 2016," wrote contributor Joanna Lewis, PharmD. "Many patents for biological drugs are expiring in the next several years and there are currently more than 50 biosimilars in trials in the United States and Europe. A study estimated that biosimilars could save the United States $44 billion dollars on direct spending of biologics between 2014-2024."1Reference

1. Mulcahy A, Predmore Z, Mattke S. The cost savings potential of biosimilar drugs in the United States. https://www.rand.org/content/dam/rand/pubs/perspectives/PE100/PE127/RAND_PE127.pdf. Accessed Feb 16, 2017.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii | stock.adobe.com
Pharmacy Interior | Image Credit: Tyler Olson - stock.adobe.com
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi - stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/peopleimages.com | stock.adobe.com
Image credit: fidaolga - stock.adobe.com
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund | stock.adobe.com
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi - stock.adobe.com
© 2023 MJH Life Sciences

All rights reserved.